Elizabeth Hanna

Elizabeth Hanna

Directeur/Membre du Conseil chez TREACE MEDICAL CONCEPTS, INC.

Fortune : 260 341 $ au 31/05/2026

61 ans
Health Technology
Consumer Services
Commercial Services

Profil

Elizabeth S.
Hanna
is currently an Independent Director at Treace Medical Concepts, Inc. since 2021.
Formerly, Ms. Hanna was Chief Commercial Officer & Executive VP at Agendia, Inc. from 2022 to 2023.
From 2019 to 2022, served as President, Chief Executive Officer & Director at Clinical Genomics, Inc. From 2014 to 2018, held the roles of President & Chief Executive Officer at ShiftWise, Inc. and President & Chief Operating Officer at Origin Life Sciences, Inc. Between 2012 and 2014, was Vice President-Global Strategic Marketing and Member-Global Management Board at Johnson & Johnson and Johnson & Johnson Vision Care, Inc., respectively.
Education includes undergraduate studies at the University of Illinois and an MBA from Harvard Business School.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
19/05/2026 75 243 ( 0,12% ) 260 341 $ 31/05/2026

Postes actifs de Elizabeth Hanna

SociétésPosteDébut
TREACE MEDICAL CONCEPTS, INC. Directeur/Membre du Conseil 01/10/2021

Anciens postes connus de Elizabeth Hanna

SociétésPosteFin
Corporate Officer/Principal 01/09/2023
Directeur Général 01/03/2022
Directeur Général 01/09/2018
President 01/01/2018
JOHNSON & JOHNSON Sales & Marketing 01/04/2014
Voir l'expérience en détail de Elizabeth Hanna

Formation de Elizabeth Hanna

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

71

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Electronic Technology

Health Technology

Consumer Services

Health Services

  1. Bourse
  2. Insiders
  3. Elizabeth Hanna